19th May 2022 9:06 am |
RNS |
ONT opens user conference, rich science programme |
13th May 2022 7:00 am |
RNS |
ONT chosen for comprehensive human genome program |
11th May 2022 4:00 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
3rd May 2022 4:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
12th Apr 2022 6:15 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
12th Apr 2022 1:01 pm |
RNS |
Director/PDMR Shareholding |
12th Apr 2022 1:01 pm |
RNS |
Director/PDMR Shareholding |
12th Apr 2022 1:00 pm |
RNS |
Director/PDMR Shareholding |
12th Apr 2022 7:00 am |
RNS |
Publication of Annual Report and Notice of AGM |
6th Apr 2022 1:00 pm |
RNS |
Block listing Interim Review |
5th Apr 2022 11:00 am |
RNS |
Director/PDMR Shareholding |
4th Apr 2022 2:00 pm |
RNS |
Genomics England expands Nanopore use in cancer |
1st Apr 2022 5:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
1st Apr 2022 7:00 am |
RNS |
Agreement |
30th Mar 2022 2:00 pm |
RNS |
ONT shows new high-accuracy, high-output chemistry |
24th Mar 2022 7:00 am |
RNS |
Nanopore sequencing profiles TB: FIND evaluation |
23rd Mar 2022 2:02 pm |
RNS |
Oxford Nanopore releases Short Fragment Mode |
22nd Mar 2022 7:00 am |
RNS |
Preliminary Results and Guidance Update |
11th Mar 2022 5:00 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
10th Mar 2022 12:30 pm |
RNS |
Holding(s) in Company |
8th Mar 2022 7:03 am |
RNS |
Publication: Nanopore IDs >50 genetic diseases |
1st Mar 2022 5:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
24th Feb 2022 7:00 am |
RNS |
Notice of Results |
11th Feb 2022 5:30 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
1st Feb 2022 5:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
24th Jan 2022 3:00 pm |
RNS |
Appointment of Senior Independent Director |
18th Jan 2022 1:00 pm |
RNS |
Holding(s) in Company |
13th Jan 2022 7:00 am |
RNS |
Fastest human genome sequence uses Oxford Nanopore |
11th Jan 2022 6:00 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
7th Jan 2022 12:00 pm |
RNS |
Update to FY21 revenue guidance |
7th Jan 2022 7:00 am |
RNS |
Company to present at JP Morgan Healthcare conf |
4th Jan 2022 6:30 pm |
RNS |
Issue of Equity and Total Voting Rights |
20th Dec 2021 5:00 pm |
RNS |
Holding(s) in Company |
13th Dec 2021 6:15 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
2nd Dec 2021 7:00 am |
RNS |
Oxford Nanopore announces technology updates |
1st Dec 2021 7:00 am |
RNS |
Issue of Equity and Total Voting Rights |
9th Nov 2021 7:03 am |
RNS |
Update to revenue guidance |
3rd Nov 2021 6:00 pm |
RNS |
Holding(s) in Company |
1st Nov 2021 6:30 pm |
RNS |
PDMR Notification (ESPP) and Director Declaration |
1st Nov 2021 7:00 am |
RNS |
Issue of Equity and Total Voting Rights |